Gary M. Franklin
Gary M. Franklin has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Deborah Fulton-Kehoe
University of Washington
6 shared publicationsJudith A. Turner
University of Washington
5 shared publicationsThomas M. Wickizer
Ohio State University
3 shared publicationsBert D. Stover
From the *Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA; †Washington State Department of Labor and Industries, Olympia, WA; and Departments of ‡Psychiatry and Behavioral Sciences, §Rehabilitation Medicine, and ¶Health Services, University of Washington, Seattle, WA
1 shared publication- Brook I. Martin
The Dartmouth Institute for Health Policy and Clinical Practice, The Department of Orthopaedic Surgery at Dartmouth-Hitchcock Medical Center, One Medical Center Dr., Lebanon, NH
1 shared publication Cynthia Bradley
From the Occupational Epidemiology and Health Outcomes Program (Dr. FranklinD. Fulton-Kehoe, C. Bradley, and T. Smith-Weller), Department of Environmental Health, University of Washington School of Public Health and Community Medicine, Seattle; the Department of Neurology (Dr. Franklin), University of Washington School of Medicine, Seattle; and the Washington State Department of Labor and Industries (Dr. Franklin), Olympia, WA
1 shared publication
Latest Publications
- 1 July 2014
- Published by Elsevier in The Spine Journal
- Vol. 14 (7) , 1237-1246
How do coverage policies influence practice patterns, safety, and cost of initial lumbar fusion surgery? A population-based comparison of workers' compensation systems
- 1 July 2014
- Published by Elsevier in The Spine Journal
- Vol. 14 (7) , 1237-1246
How do coverage policies influence practice patterns, safety, and cost of initial lumbar fusion surgery? A population-based comparison of workers' compensation systems
- 1 November 2009
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 25 (9) , 743-751
Opioid Use for Chronic Low Back Pain
Objectives To determine (1) the natural history of prescription opioid use, (2) the predictors of long-term opioid use, and (3) the association between opioid dose and pain and function in a large cohort of workers with recent back injuries. Methods Prospective cohort of workers with back injuries (N=1883) interviewed 18 days (median) and 1 year after claim submission. Detailed pharmacy data were obtained from computerized records of paid bills. Results Forty-two percent of workers (781/1843) received an opioid in the year after injury, most (694/781, 89%) at or shortly after the first medical visit for the injury. Of these, most (410/694, 59%) received opioids only within the first quarter after injury, whereas 16% (111/694) received opioids for 4 quarters. Among these long-term users, total morphine equivalent dose (MED) increased significantly (P<0.01) from the first (mean, 2364 mg; standard deviation, 4019 mg) to the fourth (mean, 3824 mg; standard deviation, 5998 mg) quarter. Improvement by at least 30% in pain and function measure scores occurred in only 26% (95% confidence interval 18%-36%) and 16% (95% confidence interval 10%-25%), respectively, of long-term users. Opioid doses increased substantially over time in all but those in whom function improved. After adjustment for baseline pain, function, and injury severity, the strongest predictor of longer term opioid prescription was total MED in the first quarter. Workers receiving at least 40 mg MED per day in the first quarter had 6-fold odds of receiving longer-term opioids. Discussions For the small group of workers with compensable back injuries who receive opioids longer-term (111/1843, 6%), opioid doses increase substantially and only a minority shows clinically important improvement in pain and function. The amount of prescribed opioid received early after injury strongly predicts long-term use. More research is needed to understand clinical decisions to continue or increase opioid therapy after back injury.
- 1 November 2009
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 25 (9) , 743-751
Opioid Use for Chronic Low Back Pain
Objectives To determine (1) the natural history of prescription opioid use, (2) the predictors of long-term opioid use, and (3) the association between opioid dose and pain and function in a large cohort of workers with recent back injuries. Methods Prospective cohort of workers with back injuries (N=1883) interviewed 18 days (median) and 1 year after claim submission. Detailed pharmacy data were obtained from computerized records of paid bills. Results Forty-two percent of workers (781/1843) received an opioid in the year after injury, most (694/781, 89%) at or shortly after the first medical visit for the injury. Of these, most (410/694, 59%) received opioids only within the first quarter after injury, whereas 16% (111/694) received opioids for 4 quarters. Among these long-term users, total morphine equivalent dose (MED) increased significantly (P<0.01) from the first (mean, 2364 mg; standard deviation, 4019 mg) to the fourth (mean, 3824 mg; standard deviation, 5998 mg) quarter. Improvement by at least 30% in pain and function measure scores occurred in only 26% (95% confidence interval 18%-36%) and 16% (95% confidence interval 10%-25%), respectively, of long-term users. Opioid doses increased substantially over time in all but those in whom function improved. After adjustment for baseline pain, function, and injury severity, the strongest predictor of longer term opioid prescription was total MED in the first quarter. Workers receiving at least 40 mg MED per day in the first quarter had 6-fold odds of receiving longer-term opioids. Discussions For the small group of workers with compensable back injuries who receive opioids longer-term (111/1843, 6%), opioid doses increase substantially and only a minority shows clinically important improvement in pain and function. The amount of prescribed opioid received early after injury strongly predicts long-term use. More research is needed to understand clinical decisions to continue or increase opioid therapy after back injury.
- 15 January 2008
- Published by Wolters Kluwer Health in Spine
- Vol. 33 (2) , 199-204
Early Opioid Prescription and Subsequent Disability Among Workers With Back Injuries
Study Design. Prospective, population-based cohort study. Objective. To examine whether prescription of opioids within 6 weeks of low back injury is associated with work disability at 1 year. Summary of Background Data. Factors related to early medical treatment have been little investigated as possible risk factors for development of long-term work disability among workers with back injuries. We have previously shown that about 1 of 3 of workers receive an opioid prescription early after a low back injury, and a recent study suggested that such prescriptions may increase risk for subsequent disability. Methods. We analyzed detailed data reflecting paid bills for opioids prescribed within 6 weeks of the first medical visit for a back injury among 1843 workers with lost work-time claims. Additional baseline measures included an injury severity rating from medical records, and demographic, psychosocial, pain, function, smoking, and alcohol measures from a worker survey conducted 18 days (median) after receipt of the back injury claim. Computerized database records of work disability 1 year after claim submission were obtained for the primary outcome measure. Results. Nearly 14% (254 of 1843) of the sample were receiving work disability compensation at 1 year. More than one-third of the workers (630 of 1843) received an opioid prescription within 6 weeks, and 50.7% of these (319 of 630) were received at the first medical visit. After adjustment for pain, function, injury severity, and other baseline covariates, receipt of opioids for more than 7 days (odds ratio = 2.2; 95% confidence interval, 1.5–3.1) and receipt of more than 1 opioid prescription were associated significantly with work disability at 1 year. Conclusion. Prescription of opioids for more than 7 days for workers with acute back injuries is a risk factor for long-term disability. Further research is needed to elucidate this association.
- 15 January 2008
- Published by Wolters Kluwer Health in Spine
- Vol. 33 (2) , 199-204
Early Opioid Prescription and Subsequent Disability Among Workers With Back Injuries
Study Design. Prospective, population-based cohort study. Objective. To examine whether prescription of opioids within 6 weeks of low back injury is associated with work disability at 1 year. Summary of Background Data. Factors related to early medical treatment have been little investigated as possible risk factors for development of long-term work disability among workers with back injuries. We have previously shown that about 1 of 3 of workers receive an opioid prescription early after a low back injury, and a recent study suggested that such prescriptions may increase risk for subsequent disability. Methods. We analyzed detailed data reflecting paid bills for opioids prescribed within 6 weeks of the first medical visit for a back injury among 1843 workers with lost work-time claims. Additional baseline measures included an injury severity rating from medical records, and demographic, psychosocial, pain, function, smoking, and alcohol measures from a worker survey conducted 18 days (median) after receipt of the back injury claim. Computerized database records of work disability 1 year after claim submission were obtained for the primary outcome measure. Results. Nearly 14% (254 of 1843) of the sample were receiving work disability compensation at 1 year. More than one-third of the workers (630 of 1843) received an opioid prescription within 6 weeks, and 50.7% of these (319 of 630) were received at the first medical visit. After adjustment for pain, function, injury severity, and other baseline covariates, receipt of opioids for more than 7 days (odds ratio = 2.2; 95% confidence interval, 1.5–3.1) and receipt of more than 1 opioid prescription were associated significantly with work disability at 1 year. Conclusion. Prescription of opioids for more than 7 days for workers with acute back injuries is a risk factor for long-term disability. Further research is needed to elucidate this association.
- 19 July 2005
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 48 (2) , 91-99
Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002
Background The use of opioids for chronic non‐cancer pain has increased in the United States since state laws were relaxed in the late 1990s. These policy changes occurred despite scanty scientific evidence that chronic use of opioids was safe and effective. Methods We examined opiate prescriptions and dosing patterns (from computerized databases, 1996 to 2002), and accidental poisoning deaths attributable to opioid use (from death certificates, 1995 to 2002), in the Washington State workers' compensation system. Results Opioid prescriptions increased only modestly between 1996 and 2002. However, prescriptions for the most potent opioids (Schedule II), as a percentage of all scheduled opioid prescriptions (II, III, and IV), increased from 19.3% in 1996 to 37.2% in 2002. Among long‐acting opioids, the average daily morphine equivalent dose increased by 50%, to 132 mg/day. Thirty‐two deaths were definitely or probably related to accidental overdose of opioids. The majority of deaths involved men (84%) and smokers (69%). Conclusions The reasons for escalating doses of the most potent opioids are unknown, but it is possible that tolerance or opioid‐induced abnormal pain sensitivity may be occurring in some workers who use opioids for chronic pain. Opioid‐related deaths in this population may be preventable through use of prudent guidelines regarding opioid use for chronic pain. Am. J. Ind. Med. 48:91–99, 2005.
- 19 July 2005
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 48 (2) , 91-99
Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002
Background The use of opioids for chronic non‐cancer pain has increased in the United States since state laws were relaxed in the late 1990s. These policy changes occurred despite scanty scientific evidence that chronic use of opioids was safe and effective. Methods We examined opiate prescriptions and dosing patterns (from computerized databases, 1996 to 2002), and accidental poisoning deaths attributable to opioid use (from death certificates, 1995 to 2002), in the Washington State workers' compensation system. Results Opioid prescriptions increased only modestly between 1996 and 2002. However, prescriptions for the most potent opioids (Schedule II), as a percentage of all scheduled opioid prescriptions (II, III, and IV), increased from 19.3% in 1996 to 37.2% in 2002. Among long‐acting opioids, the average daily morphine equivalent dose increased by 50%, to 132 mg/day. Thirty‐two deaths were definitely or probably related to accidental overdose of opioids. The majority of deaths involved men (84%) and smokers (69%). Conclusions The reasons for escalating doses of the most potent opioids are unknown, but it is possible that tolerance or opioid‐induced abnormal pain sensitivity may be occurring in some workers who use opioids for chronic pain. Opioid‐related deaths in this population may be preventable through use of prudent guidelines regarding opioid use for chronic pain. Am. J. Ind. Med. 48:91–99, 2005.
- 1 July 2004
- Published by Elsevier in Neurotherapeutics
- Vol. 1 (3) , 356-362
Policy-relevant research: When does it matter?
- 1 July 2004
- Published by Elsevier in Neurotherapeutics
- Vol. 1 (3) , 356-362
Policy-relevant research: When does it matter?
- Open Access
- 24 May 2004
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 5 (1) , 14
Prediction of chronic disability in work-related musculoskeletal disorders: a prospective, population-based study
Disability associated with work-related musculoskeletal disorders is an increasingly serious societal problem. Although most injured workers return quickly to work, a substantial number do not. The costs of chronic disability to the injured worker, his or her family, employers, and society are enormous. A means of accurate early identification of injured workers at risk for chronic disability could enable these individuals to be targeted for early intervention to promote return to work and normal functioning. The purpose of this study is to develop statistical models that accurately predict chronic work disability from data obtained from administrative databases and worker interviews soon after a work injury. Based on these models, we will develop a brief instrument that could be administered in medical or workers' compensation settings to screen injured workers for chronic disability risk. This is a population-based, prospective study. The study population consists of workers who file claims for work-related back injuries or carpal tunnel syndrome (CTS) in Washington State. The Washington State Department of Labor and Industries claims database is reviewed weekly to identify workers with new claims for work-related back injuries and CTS, and these workers are telephoned and invited to participate. Workers who enroll complete a computer-assisted telephone interview at baseline and one year later. The baseline interview assesses sociodemographic, employment-related, biomedical/health care, legal, and psychosocial risk factors. The follow-up interview assesses pain, disability, and work status. The primary outcome is duration of work disability over the year after claim submission, as assessed by administrative data. Secondary outcomes include work disability status at one year, as assessed by both self-report and work disability compensation status (administrative records). A sample size of 1,800 workers with back injuries and 1,200 with CTS will provide adequate statistical power (0.96 for low back and 0.85 for CTS) to predict disability with an alpha of .05 (two-sided) and a hazard ratio of 1.2. Proportional hazards regression models will be constructed to determine the best combination of predictors of work disability duration at one year. Regression models will also be developed for the secondary outcomes.
- 24 May 2004
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 5 (1) , 14
Open AccessPrediction of chronic disability in work-related musculoskeletal disorders: a prospective, population-based study
Disability associated with work-related musculoskeletal disorders is an increasingly serious societal problem. Although most injured workers return quickly to work, a substantial number do not. The costs of chronic disability to the injured worker, his or her family, employers, and society are enormous. A means of accurate early identification of injured workers at risk for chronic disability could enable these individuals to be targeted for early intervention to promote return to work and normal functioning. The purpose of this study is to develop statistical models that accurately predict chronic work disability from data obtained from administrative databases and worker interviews soon after a work injury. Based on these models, we will develop a brief instrument that could be administered in medical or workers' compensation settings to screen injured workers for chronic disability risk. This is a population-based, prospective study. The study population consists of workers who file claims for work-related back injuries or carpal tunnel syndrome (CTS) in Washington State. The Washington State Department of Labor and Industries claims database is reviewed weekly to identify workers with new claims for work-related back injuries and CTS, and these workers are telephoned and invited to participate. Workers who enroll complete a computer-assisted telephone interview at baseline and one year later. The baseline interview assesses sociodemographic, employment-related, biomedical/health care, legal, and psychosocial risk factors. The follow-up interview assesses pain, disability, and work status. The primary outcome is duration of work disability over the year after claim submission, as assessed by administrative data. Secondary outcomes include work disability status at one year, as assessed by both self-report and work disability compensation status (administrative records). A sample size of 1,800 workers with back injuries and 1,200 with CTS will provide adequate statistical power (0.96 for low back and 0.85 for CTS) to predict disability with an alpha of .05 (two-sided) and a hazard ratio of 1.2. Proportional hazards regression models will be constructed to determine the best combination of predictors of work disability duration at one year. Regression models will also be developed for the secondary outcomes.
- 28 March 2000
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (6) , 1252-1258
Outcome of surgery for thoracic outlet syndrome in Washington state workers’ compensation
Objective: To determine the predictors of outcome of thoracic outlet syndrome (TOS) surgery in a population-based cohort of injured workers. Methods: All injured workers in the Washington State Workers’ Compensation system who received TOS surgery during 1986 to 1991 were identified by computerized bill payment records and validated by medical record review (n = 158). The main outcome measure was work disability status 1 year after surgery. Additional functional status and quality of life outcomes were determined by telephone survey an average of 4.8 years after operation. A sample of workers with a TOS diagnosis who did not receive surgery during 1987 to 1989 were identified as a comparison group (n = 95). Results: Sixty percent of workers were still work disabled 1 year after surgery. The strongest predictors of remaining disabled were the amount of work disability before surgery (OR = 1.85; 95% CI, 1.51 to 2.28), longer time between injury and TOS diagnosis (OR = 1.34; 95% CI, 1.09 to 1.64), and older age at injury (OR = 1.07; 95% CI, 1.00 to 1.13). There was no relationship between type of surgery, presence of any provocative tests, or experience of surgeon and work disability outcome. In follow-up surveys an average of 4.8 years after surgery, 72.5% of workers still reported they were “limited a lot” in vigorous activities. Compared with a nonsurgical sample of TOS patients, those receiving surgery had 50% greater medical costs and were three to four times more likely to be work disabled. Conclusions: The outcome of TOS surgery among injured workers is worse than has generally been reported. The nonspecific neurogenic TOS diagnosis, the complexity of workers’ compensation cases, and the adverse event profile are likely substantial contributors to the worse outcomes reported here. Well-designed prospective studies and randomized trials are required to elucidate any role of TOS surgery in nonspecific TOS.
- 28 March 2000
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (6) , 1252-1258
Outcome of surgery for thoracic outlet syndrome in Washington state workers’ compensation
Objective: To determine the predictors of outcome of thoracic outlet syndrome (TOS) surgery in a population-based cohort of injured workers. Methods: All injured workers in the Washington State Workers’ Compensation system who received TOS surgery during 1986 to 1991 were identified by computerized bill payment records and validated by medical record review (n = 158). The main outcome measure was work disability status 1 year after surgery. Additional functional status and quality of life outcomes were determined by telephone survey an average of 4.8 years after operation. A sample of workers with a TOS diagnosis who did not receive surgery during 1987 to 1989 were identified as a comparison group (n = 95). Results: Sixty percent of workers were still work disabled 1 year after surgery. The strongest predictors of remaining disabled were the amount of work disability before surgery (OR = 1.85; 95% CI, 1.51 to 2.28), longer time between injury and TOS diagnosis (OR = 1.34; 95% CI, 1.09 to 1.64), and older age at injury (OR = 1.07; 95% CI, 1.00 to 1.13). There was no relationship between type of surgery, presence of any provocative tests, or experience of surgeon and work disability outcome. In follow-up surveys an average of 4.8 years after surgery, 72.5% of workers still reported they were “limited a lot” in vigorous activities. Compared with a nonsurgical sample of TOS patients, those receiving surgery had 50% greater medical costs and were three to four times more likely to be work disabled. Conclusions: The outcome of TOS surgery among injured workers is worse than has generally been reported. The nonspecific neurogenic TOS diagnosis, the complexity of workers’ compensation cases, and the adverse event profile are likely substantial contributors to the worse outcomes reported here. Well-designed prospective studies and randomized trials are required to elucidate any role of TOS surgery in nonspecific TOS.
- 25 September 1998
- p. SP178-86
Device evaluation and coverage policy in workers' compensation: examples from Washington State.
Workers' compensation health benefits are broader than general health benefits and include payment for medical and rehabilitation costs, associated indemnity (lost time) costs, and vocational rehabilitation (return-to-work) costs. In addition, cost liability is for the life of the claim (injury), rather than for each plan year. We examined device evaluation and coverage policy in workers' compensation over a 10-year period in Washington State. Most requests for device coverage in workers' compensation relate to the diagnosis, prognosis, or treatment of chronic musculoskeletal conditions. A number of specific problems have been recognized in making device coverage decisions within workers' compensation: (1) invasive devices with a high adverse event profile and history of poor outcomes could significantly increase both indemnity and medical costs; (2) many noninvasive devices, while having a low adverse event profile, have not proved effective for managing chronic musculoskeletal conditions relevant to injured workers; (3) some devices are marketed and billed as surrogate diagnostic tests for generally accepted, and more clearly proven, standard tests; (4) quality oversight of technology use among physicians may be inadequate; and (5) insurers' access to efficacy data adequate to make timely and appropriate coverage decisions in workers' compensation is often lacking. Emerging technology may substantially increase the costs of workers' compensation without significant evidence of health benefit for injured workers. To prevent ever-rising costs, we need to increase provider education and patient education and consent, involve the state medical society in coverage policy, and collect relevant outcomes data from healthcare providers.
- 25 September 1998
- p. SP178-86
Device evaluation and coverage policy in workers' compensation: examples from Washington State.
Workers' compensation health benefits are broader than general health benefits and include payment for medical and rehabilitation costs, associated indemnity (lost time) costs, and vocational rehabilitation (return-to-work) costs. In addition, cost liability is for the life of the claim (injury), rather than for each plan year. We examined device evaluation and coverage policy in workers' compensation over a 10-year period in Washington State. Most requests for device coverage in workers' compensation relate to the diagnosis, prognosis, or treatment of chronic musculoskeletal conditions. A number of specific problems have been recognized in making device coverage decisions within workers' compensation: (1) invasive devices with a high adverse event profile and history of poor outcomes could significantly increase both indemnity and medical costs; (2) many noninvasive devices, while having a low adverse event profile, have not proved effective for managing chronic musculoskeletal conditions relevant to injured workers; (3) some devices are marketed and billed as surrogate diagnostic tests for generally accepted, and more clearly proven, standard tests; (4) quality oversight of technology use among physicians may be inadequate; and (5) insurers' access to efficacy data adequate to make timely and appropriate coverage decisions in workers' compensation is often lacking. Emerging technology may substantially increase the costs of workers' compensation without significant evidence of health benefit for injured workers. To prevent ever-rising costs, we need to increase provider education and patient education and consent, involve the state medical society in coverage policy, and collect relevant outcomes data from healthcare providers.